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Introduction
Cancer is the leading cause of death in developed 
countries and is the second leading cause of death in 
developing countries (Jemal et al., 2011). The global 
cancer burden is still increasing in economical developing 
countries due to an aging population and the growth of 
the world population with an increase of cancer-causing 
behaviors, particularly smoking (Jemal et al., 2011; 
Ghoncheh et al., 2015a). Although the overall incidence 
of cancer in developing countries is as much as half of 
the world’s developed countries in both sexes, generally 
overall cancer death rate in these countries is similar and 
cancer survival tends to be poorer in developing countries 
(Jemal et al., 2010; Jemal et al., 2011). 
According to the World 2008 global statistics, 
colorectal cancer is the second most common cancer 
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Abstract
 Background: This study aimed to investigate the standardized incidence and mortality rate of colorectal 
cancer and its relationship with the human development index (HDI) across the world in 2012. Materials and 
Methods: This ecologic study was conducted for assessment of the correlation between age-specific incidence 
rate (ASIR) and age-specific mortality rate (ASMR) with HDI and its components. Data for SIR and SMR for 
every country for the year 2012 were obtained from the global cancer project. We used a bivariate method for 
assessment of the correlation between SIR and SMR and HDI. Statistical significance was assumed at P<0.05. 
Statistical analyses were performed using SPSS (Version 22.0, SPSS Inc.). Results: Countries with the highest 
SIR of colorectal cancer in the world in 2012, were Republic of Korea, Slovakia, Hungary and countries with 
the highest SMR were Hungary, Croatia and Slovakia. The correlation between SIR of colorectal cancer and 
the HDI was 0.712 (P≤0.001), with life expectancy at birth 0.513 (P≤0.001), with mean years of schooling 0.641 
(P≤0.001) and with level of income per each person of the population 0.514 (P=0.013). In addition, the correlation 
between SMR of colorectal cancer and the HDI was 0.628 (P≤0.001), with life expectancy at birth 0.469 (P≤0.001), 
with mean years of schooling 0.592 (P≤0.001) and with level of income per each person of the population 0.378 
(P=0.013). Conclusions: The highest SIR and SMR of colorectal cancer was in the WHO Europe region. There 
was a positive correlation between HDI and SIR and SMR of colorectal cancer. 
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worldwide after lung and breast cancers which, according 
to sex, for men and women is the third and the second most 
common cancer respectively (Jemal et al., 2011; Singh et 
al., 2014). Although appearance of new diagnostic and 
screening tests for this cancer has reduced the incidence 
and mortality of that in developed countries (Baxter et al., 
2012; Zauber et al., 2012), but yet this cancer accounts 
for about 12% of all cancer incidences and incidence 
and mortality rate of this cancer has an increasing trend 
in developing countries (Jemal et al., 2010; Jemal et 
al., 2011; Hajmanoochehri et al., 2014). Various studies 
have shown relationship between development indexes, 
incidence and mortality of types of cancers (Pakzad et al., 
2014; Ghoncheh et al., 2015b). One of these indicators 
is human development index (HDI) which consists of 
three components: longevity (life expectancy at birth), 
knowledge (adult literacy rate and average years of 
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schooling) and income (the internal impure income 
capitation in purchasing power- in dollars). The numerical 
value of HDI is between zero and one. This index divides 
world countries into four general categories: Countries 
with too high HDI (HD≥0.9), Countries with high HDI 
(HDI≥0.8), countries with moderate HDI (0.5<HDI<0.8) 
and countries with low HDI (HDI≤0.5) (Programme, 
2015). Studies done in Asian countries have shown a 
relation between the incidence and mortality of breast 
and bladder cancer and the Human Development Index 
(HDI) and associated components of this index (Pakzad 
et al., 2014; Ghoncheh et al., 2015b; Pakzad et al., 2015).
The incidence of colorectal cancer in some low-risk 
areas including Spain and Eastern Asia and Eastern Europe 
is increasing rapidly. Some of the undesirable trends 
are affected by the combination of risk factors such as 
diet, obesity and smoking and also the downward trend 
in developed Western countries is due to the advent of 
screening and diagnostic tests. Mutable risk factors for 
colorectal cancer include smoking, physical activity, 
overweight and obesity, consumption of red and processed 
meat and high alcohol consumption. Population-based 
screening plans are only feasible for economically 
developing countries and these program’s focus is for 
countries with a Western lifestyle. Some risk factors can 
be associated with the HDI and its components and affect 
the incidence and mortality of cancer as a result (Corrao 
et al., 2000; Giebel et al., 2010; Bray et al., 2012; Ferrari 
and Reis, 2013; Liu et al., 2013). Due to the importance of 
awareness about the incidence and mortality of colorectal 
cancer in better planning and the possible relation between 
incidence and mortality of this cancer and developing 
index, this study aimed to investigate the standardized 
incidence and mortality rate of colorectal cancer and its 
relationship with HDI in the world in 2012. Data about 
the age-specific incidence and mortality rate (ASR) for 
every country for year 2012 get from global cancer project 
(Almasi et al., 2015) and HDI from Human Development 
Report 2013 (Malik, 2013) that include information about 
HDI and its details for every country for year 2012. 
Materials and Methods
Age-specific incidence rate estimate 
The methods of estimation are country specific and 
the quality of the estimation depends upon the quality 
and on the amount of the information available for each 
country. In theory, there are as many methods as countries, 
and because of the variety and the complexity of these 
methods, an overall quality score for the incidence and 
mortality estimates combined is almost impossible to 
establish. However an alpha numeric scoring system 
which independently describes the availability of 
incidence and mortality data has been established at 
the country level. The combined score is presented 
together with the estimates for each country with an aim 
of providing a broad indication of the robustness of the 
estimation.
The methods to estimate the sex- and age-specific 
incidence rates of cancer for a specific country fall into 
one of the following broad categories, in priority order:
1- Rates projected to 2012 (38 countries)-2- Most 
recent rates applied to 2012 population (20 countries)-
3-Estimated from national mortality by modelling, using 
incidence mortality ratios derived from recorded data 
in country-specific cancer registries (13 countries)-4- 
Estimated from national mortality estimates by modelling, 
using incidence mortality ratios derived from recorded 
data in local cancer registries in neighboring countries (9 
European countries)-5-Estimated from national mortality 
estimates using modelled survival (32 countries)-6- 
Estimated as the weighted average of the local rates 
(16 countries)-7- One cancer registry covering part of a 
country is used as representative of the country profile (11 
countries)-8-Age/sex specific rates for “all cancers” were 
partitioned using data on relative frequency of different 
cancers (by age and sex) (12 countries)-9- The rates are 
those of neighboring countries or registries in the same 
area (33 countries) (Almasi et al., 2015; Ferlay et al., 2015; 
Razi et al., 2015).
Age-specific mortality rate estimate 
Depending of the degree of detail and accuracy of the 
national mortality data, six methods have been utilized 
in the following order of priority: 1-Rates projected to 
2012 (69 countries)-2- Most recent rates applied to 2012 
population (26 countries)-3- Estimated as the weighted 
average of regional rates (1 country)-4- Estimated 
from national incidence estimates by modelling, using 
country-specific survival (2 countries)-5-Estimated from 
national incidence estimates using modelled survival (83 
countries)-6-The rates are those of neighboring countries 
or registries in the same area (3 countries) (Almasi et al., 
2015; Ferlay et al., 2015; Razi et al., 2015).
HDI
HDI, a composite measure of indicators along three 
dimensions: life expectancy, educational attainment and 
command over the resources needed for a decent living. 
All groups and regions have seen notable improvement 
in all HDI components, with faster progress in low 
and medium HDI countries. On this basis, the world is 
becoming less unequal. Nevertheless, national averages 
hide large variations in human experience. Wide disparities 
remain within countries of both the North and the South, 
and income inequality within and between many countries 
has been rising (Malik, 2013).
Data analysis
In this study, we use of correlation bivariate method for 
assessment the correlation between age-specific incidence 
and mortality rate (ASR) with Human Development Index 
(HDI) and its details that include: Life expectancy at birth, 
Mean years of schooling and Gross national income (GNI) 
per capita. Statistical significance was assumed if P< 0.05. 
All reported P-values are two-sided. Statistical analyses 
were performed using SPSS (Version 15.0, SPSS Inc).
Results 
Cancer Incidence in World Regions
In total, 1,360,602 cases of colorectal cancer are 
Asian Pacific Journal of Cancer Prevention, Vol 17, 2016 2467
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.5.2465
Colorectal Cancer Incidence and Mortality Correlations with the Human Development Index 
recorded in the world in 2012 that 746,298 cases (85/54%) 
were men and 614,304 cases (14/45%) were women (see 
Table 1). The sex ratio for disease is 1/21.The world’s 
10 countries with the highest number of new colorectal 
cancer cases are as follows respectively: 1.China with 
253,427 cases, 2.United States of America with 134,349 
cases, 3. Japan with 112,675 cases, 4.India with 64,332 
cases, 5.Germany with 63,572 cases, 6. Russian Federation 
with 59,928 cases, 7. Italy with 48,110 cases, 8. France 
(metropolitan) with 40,825 Cases, 9. United Kingdom 
with 40,755 cases and 10. Brazil with 33,949 cases and 
these Ten Countries allocated a total of 851922 (62%) 
of cases in the world. the world’s ten countries with the 
highest standardized incidence of colorectal cancer are 
as follows respectively: 1.Republic of Korea with the 
standardized incidence rate of 45 per hundred thousand 
people, 2. Slovakia with 42.7 per hundred thousand 
people, 3. Hungary with 42.3 per hundred thousand 
people, 4.Denmark with 40.5 per hundred thousand 
people, 5. The Netherlands with 40.2 per hundred thousand 
people, 6. Czech Republic with the standardized incidence 
rate of 38.9 per hundred thousand people, 7. Norway 
with 38.9 per hundred thousand people, 8. Australia 
with 38.4 per hundred thousand people, 9. New Zealand 
with 37.3 per hundred thousand people and 10. Slovenia 
with 37 per hundred thousand people. Similarly, the 10 
countries which have the lowest standardized incidence 
rate of colorectal cancer are: 1.Mozambique with 1.2 per 
Table 1. The Number and Rate of the Crude and Standardized Colorectal Cancer Incidence in the World in 
2012 (Sorted by Age-Standardized Rate from the Highest Value to the Lowest)
Colorectal - Estimated Incidence, All Ages: Both Sexes Colorectal - Estimated Incidence, All Ages: Male Colorectal - Estimated Incidence, All Ages: Female
PO
PU
LA
TI
ON
Nu
mb
ers
Cr
ud
e R
ate
AS
R 
(W
)
PO
PU
LA
TI
ON
Nu
mb
ers
Cr
ud
e R
ate
AS
R 
(W
)
PO
PU
LA
TI
ON
Nu
mb
ers
Cr
ud
e R
ate
AS
R 
(W
)
Australia/New Zealand 18887 69.0 38.2 Australia/New Zealand 10345 75.9 44.8 Australia/New Zealand 8542 62.1 32.2
Oceania 19536 51.8 34.8 Oceania 10721 56.7 41.0 Oceania 8815 46.8 29.2
Western Europe 137109 72.3 31.4 European Union 
(EU-28)
193426 77.9 39.5 Northern Europe 29890 58.7 25.3
European Union (EU-28) 345346 68.0 31.3 Southern Europe 60029 77.5 39.5 Western Europe 60917 63.0 24.9
Southern Europe 105009 66.7 31.1 Western Europe 76192 82.0 39.1 European Union (EU-
28)
151920 58.6 24.4
Very High Human 
Development
702196 60.9 30.6 Very High Human 
Development
388706 68.3 37.9 Very High Human 
Development
313490 53.7 24.4
Northern Europe 65162 65.0 30.4 Europe 241813 67.6 37.3 Southern Europe 44980 56.2 24.1
Europe 447136 60.3 29.5 Northern Europe 35272 71.4 36.5 Europe 205323 53.5 23.6
More developed regions 736867 59.2 29.2 More developed regions 398903 65.8 36.3 More developed regions 337964 52.8 23.6
WHO Europe region 
(EURO)
471240 52.2 28.2 WHO Europe region 
(EURO)
254769 58.3 35.7 Northern America 75912 42.8 22.7
Central and Eastern Europe 139856 47.6 26.6 Central and Eastern 
Europe
70320 51.0 34.5 WHO Europe region 
(EURO)
216471 46.5 22.6
Northern America 158169 45.1 26.1 Northern America 82257 47.5 30.1 Central and Eastern 
Europe
69536 44.6 21.7
IARC membership (24 
countries)
769099 29.4 21.6 IARC membership (24 
countries)
417775 31.8 26.2 IARC membership (24 
countries)
351324 27.0 17.8
Micronesia 99 18.1 20.4 Micronesia 58 21.0 24.8 WHO Americas region 
(PAHO)
120564 25.0 17.6
WHO Americas region 
(PAHO)
245643 25.8 19.8 Eastern Asia 243157 29.7 22.4 Micronesia 41 15.1 16.6
Eastern Asia 421343 26.5 18.4 WHO Americas region 
(PAHO)
125079 26.6 22.3 Caribbean 4557 21.4 16.6
WHO Western Pacific 
region (WPRO)
459958 25.0 18.3 WHO Western Pacific 
region (WPRO)
264479 28.0 22.3 High Human 
Development
106740 20.1 15.7
High Human Development 210612 20.2 17.5 World 746298 21.0 20.6 WHO Western Pacific 
region (WPRO)
195479 21.8 14.6
World 1360602 19.3 17.2 High Human 
Development
103872 20.3 19.9 Eastern Asia 178186 23.2 14.6
Caribbean 8409 19.9 16.4 Micronesia/Polynesia 97 15.5 18.5 South America 34510 17.0 14.6
South America 67464 16.8 15.7 Western Asia 15112 12.2 17.6 World 614304 17.6 14.3
Micronesia/Polynesia 163 13.2 15.0 South America 32954 16.7 17.1 Latin America and 
Caribbean
44652 14.6 13.0
Western Asia 27140 11.3 14.8 Asia 347514 16.0 16.5 Western Asia 12028 10.4 12.4
Latin America and Carib-
bean
87474 14.5 14.0 Caribbean 3852 18.4 16.3 Micronesia/Polynesia 66 10.9 11.8
Asia 607182 14.3 13.7 South-Eastern Asia 38538 12.8 15.2 Asia 259668 12.5 11.1
South-Eastern Asia 69016 11.4 12.5 Latin America and 
Caribbean
42822 14.4 15.1 South-Eastern Asia 30478 10.0 10.2
Less developed regions 623735 10.7 11.7 Southern Africa 2611 9.0 14.2 Less developed regions 276340 9.7 9.8
Middle-East and Northern 
Africa (MENA)
40031 8.9 11.4 Less developed regions 347395 11.8 13.7 Middle-East and 
Northern Africa 
(MENA)
18134 8.2 9.8
Medium Human 
Development
407360 11.5 11.3 Polynesia 39 11.2 13.6 Medium Human 
Development
175212 10.1 9.3
Southern Africa 4871 8.3 10.9 Medium Human 
Development
232148 12.8 13.4 Southern Africa 2260 7.7 8.7
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Colorectal - Estimated incidence, all ages: both sexes Colorectal - Estimated incidence, all ages: male Colorectal - Estimated incidence, all ages: female
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Polynesia 64 9.4 10.6 Middle-East and 
Northern Africa 
(MENA)
21897 9.6 13.2 Polynesia 25 7.5 7.9
Melanesia 486 5.3 8.8 Melanesia 279 6.0 11.1 Central America 5585 6.9 7.1
Central America 11601 7.2 8.0 WHO South-East Asia 
region (SEARO)
68235 7.2 8.9 Northern Africa 6106 5.9 6.9
Northern Africa 12891 6.2 7.6 Central America 6016 7.6 8.8 Melanesia 207 4.6 6.9
WHO South-East Asia 
region (SEARO)
120225 6.5 7.5 Northern Africa 6785 6.5 8.5 WHO East 
Mediterranean region 
(EMRO)
14664 4.8 6.6
WHO East Mediterranean 
region (EMRO)
32769 5.3 7.4 WHO East 
Mediterranean region 
(EMRO)
18105 5.7 8.3 WHO South-East Asia 
region (SEARO)
51990 5.7 6.3
Eastern Africa 12387 3.5 6.5 Eastern Africa 6228 3.6 7.1 Eastern Africa 6159 3.5 6.1
Africa 41105 3.8 6.3 South-Central Asia 50707 5.4 7.0 Africa 19934 3.7 5.8
WHO Africa region 
(AFRO)
30542 3.5 6.1 Africa 21171 3.9 7.0 WHO Africa region 
(AFRO)
15037 3.4 5.7
South-Central Asia 89683 4.9 6.1 WHO Africa region 
(AFRO)
15505 3.5 6.7 Sub-Saharan Africa 13828 3.2 5.4
Sub-Saharan Africa 28214 3.3 5.8 Sub-Saharan Africa 14386 3.3 6.4 South-Central Asia 38976 4.4 5.2
Low Human Development 39689 3.0 4.9 Low Human Develop-
ment
21183 3.2 5.5 Middle Africa 1768 2.6 4.8
Middle Africa 3291 2.5 4.8 Middle Africa 1523 2.3 4.7 Low Human 
Development
18506 2.9 4.4
Western Africa 7665 2.4 4.1 Western Africa 4024 2.5 4.5 Western Africa 3641 2.3 3.8
Table 1. (Continued) Number and Crude and Standardized Colorectal Cancer Incidence in the World in 2012 
(Sorted by Age-Standardized Rate from the Highest Value to the Lowest)
hundred thousand people, 2.The Gambia with 1.3 Per 
hundred thousand people, 3. Guinea with 1.8 per hundred 
thousand people, 4. Lesotho with 2 per hundred thousand 
people, 5. Swaziland with the standardized incidence 
rate of 2.3 per hundred thousand people, 6. Burkina Faso 
with 2.5 per hundred thousand people, 7. Comoros with 
2.7 per hundred thousand people, 8.  Liberia with 3.2 per 
hundred thousand people, 9. Nepal with 3.2 per hundred 
thousand people and 10. Cameroon with 3.3 per hundred 
thousand people.
Standardized incidence rate based on the Human 
Development Index is 30.6 per hundred thousand people 
in very High Human Developed areas, 17.5 per hundred 
thousand people in High Human developed areas, 11.3 per 
hundred thousand people in Medium Human Developed 
Figure 1. Standardized Incidence and Mortality Rates 
for Colorectal Cancer in the World in 2012
	  
Figure 2. Geographical Distribution of the Incidence 
of Colorectal Cancer in the World in 2012
	  
areas and 4.9 per hundred thousand people in Low Human 
Developed ones respectively. Also the standardized 
incidence rate in six WHO regions is 28.2 per hundred 
thousand people in WHO Europe region (EURO), 19.8 
per hundred thousand people in WHO Americas region 
(PAHO), 18.3 per hundred thousand people in WHO 
Western Pacific region (WPRO), 7.5 per hundred thousand 
Figure 3. Geographical Distribution of the Mortality 
from Colorectal Cancer in the World in 2012
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Table 2. Number and Crude and Standardized Colorectal Cancer Mortality Rates in the World in 2012 (Sorted 
by Age-Standardized Rate from the Highest Value to the Lowest)
Colorectal - Estimated mortality, all ages: both sexes Colorectal - Estimated mortality, all ages: male Colorectal - Estimated mortality, all ages: female
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Central and Eastern 
Europe
84475 28.8 14.9 Central and Eastern 
Europe
42547 30.9 20.3 Central and Eastern 
Europe
41928 26.9 11.7
Europe 214866 29.0 12.5 Europe 113246 31.7 16.2 Europe 101620 26.5 9.9
WHO Europe region 
(EURO)
228275 25.3 12.2 WHO Europe region 
(EURO)
120387 27.5 15.7 WHO Europe region 
(EURO)
107888 23.2 9.7
European Union 
(EU-28)
152046 30.0 11.8 Southern Europe 27123 35.0 15.4 More developed regions 157768 24.7 9.3
Southern Europe 48098 30.5 11.7 European Union 
(EU-28)
82959 33.4 15.2 Northern Europe 12645 24.8 9.2
More developed regions 333165 26.7 11.6 More developed 
regions
175397 28.9 14.7 Caribbean 2694 12.7 9.1
Northern Europe 26812 26.7 11.1 Very High Human 
Development
157503 27.7 13.9 European Union (EU-28) 69087 26.7 9.0
Very High Human 
Development
293259 25.4 11.0 Northern Europe 14167 28.7 13.4 Southern Europe 20975 26.2 8.7
Western Europe 55481 29.2 10.6 Western Europe 29409 31.6 13.3 High Human 
Development
62933 11.9 8.7
Australia/New Zealand 5489 20.0 10.0 High Human Develop-
ment
61926 12.1 11.7 Very High Human Devel-
opment
135756 23.3 8.7
High Human Develop-
ment
124859 12.0 10.0 Australia/New Zealand 2944 21.6 11.6 Australia/New Zealand 2545 18.5 8.5
Oceania 5888 15.6 9.7 Oceania 3172 16.8 11.4 Western Europe 26072 26.9 8.3
Northern America 63465 18.1 9.4 Northern America 33168 19.1 11.3 Oceania 2716 14.4 8.2
IARC membership (24 
countries)
353357 13.5 9.3 IARC membership (24 
countries)
186665 14.2 11.2 Northern America 30297 17.1 7.8
Caribbean 4932 11.7 9.1 Micronesia 24 8.7 10.5 South America 18988 9.4 7.7
WHO Americas region 
(PAHO)
112192 11.8 8.5 Eastern Asia 115473 14.1 10.2 IARC membership (24 
countries)
166692 12.8 7.7
South America 37335 9.3 8.5 WHO Western Pacific 
region (WPRO)
124920 13.2 10.1 WHO Americas region 
(PAHO)
55097 11.4 7.4
Western Asia 15306 6.4 8.4 Western Asia 8439 6.8 10.0 Western Asia 6867 5.9 7.1
Eastern Asia 207716 13.1 8.4 World 373639 10.5 10.0 World 320294 9.2 6.9
WHO Western Pacific 
region (WPRO)
224808 12.2 8.4 Southern Africa 1753 6.0 10.0 Latin America and Carib-
bean
24800 8.1 6.9
people in WHO South-East Asia region (SEARO), 7.7 per 
hundred thousand people in WHO East Mediterranean 
region (EMRO) and 6.1 per hundred thousand people in 
WHO Africa region (AFRO). Also it’s 29.2 and 11.7 per 
hundred thousand people in more developed regions and 
less developed regions respectively.
Geographical Distribution
 Data for geographical distribution of the relative 
incidence and mortality of colorectal cancer in the world 
in 2012 are illustrated graphically in Figures 1-3, from the 
Globocan database.  
  
Cancer Mortality in World Regions
By the other hand 693,933 deaths occurred due to 
colorectal cancer during 2012 in the world that 373,639 
(53.84%) of them were men and 320,294 (46.15%) 
were women (see Table 2). The sex ratio of the disease 
is 1.16. The highest number of deaths from colorectal 
cancer are as follows respectively: 1. China with 139416 
cases, 2. United States of America with 55259 cases, 3. 
Japan with 49345 cases, 4.  India with 48603 cases, 5. 
Russian Federation with 39907 cases, 6. Germany with 
25473 cases, 7.  Italy with 19279 cases, 8. Indonesia with 
18398 cases, 9. Brazil with 17607 cases and 10. France 
(metropolitan) with 17148 cases. A total of 430,435 cases 
(62.02%) of deaths occurred just in these ten countries.
In the world, 10 countries with the highest standardized 
mortality rates from colorectal cancer are as follows 
respectively: 1. Hungary with the standardized rate of 
20.8 per hundred thousand people, 2. Croatia with the 
rate of 18.7 per hundred thousand people, 3. Slovakia 
with the rate of 18 per hundred thousand people, 4. Serbia 
with the rate of 16.6 per hundred thousand people, 5. 
Republic of Moldova with the rate of 16.5 per hundred 
thousand people, 6. Slovenia with the standardized rate 
of 16.2 Per hundred thousand people, 7. Bulgaria with the 
rate of 16 per hundred thousand people, 8. Montenegro 
with the rate of 15.9 per hundred thousand people, 9. 
Uruguay with the rate of 15.7 per hundred thousand 
people and 10. Jordan with the rate of 15.5 per hundred 
thousand people. Similarly, the 10 countries with the 
lowest standardized mortality rates from colorectal cancer 
include: 1. Mozambique with the rate of 0.9 per hundred 
thousand people, 2. The Gambia with the rate of 1.2 per 
hundred thousand people, 3. Guinea with the rate of 1.4 
per hundred thousand people, 4. Lesotho with the rate of 
1.8 per hundred thousand people, 5. Burkina Faso with 
the rate of 2.1 per hundred thousand people, 6. Swaziland 
with the rate of 2.1 per hundred thousand people, 7. Sri 
Lanka with the rate of 2.2 per hundred thousand people, 
8. Cameroon with the rate of 2.4 per hundred thousand 
Hosein Rafiemanesh et al
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people, 9. Botswana with the rate of 2.5 per hundred 
thousand people and 10. Nepal with the rate of 2.5 per 
hundred thousand people. 
The standardized mortality rate based on the Human 
Development Index is 11, 10, 6.7 and 3.9 Per hundred 
thousand people in Very High Human Developed, High 
Human Developed, medium Human Developed and 
Low Human Developed areas respectively. Also the 
standardized incidence rate (in six WHO regions) is 12.2 
per hundred thousand people in WHO Europe region 
(EURO), 8.5 per hundred thousand people in WHO 
Americas region (PAHO), 8.4 per hundred thousand 
people in WHO Western Pacific region (WPRO), 5.3 per 
hundred thousand people in WHO South-East Asia region 
(SEARO), 4.9 per hundred thousand people in WHO 
East Mediterranean region (EMRO) and 4.6 per hundred 
thousand people in WHO Africa region (AFRO). Also 
it’s 11.6 per hundred thousand people in more developed 
regions and 4.6 per hundred thousand people in less 
developed ones. 
The number and rate of the crude and standardized 
cancer mortality rates based on gender in the world is 
presented in Table 2. Various areas of the world are 
arranged from high to low based on standardized rate 
in Table 2.  So you can see the highest and lowest 
standardized rate in any type of region. Table 2: The 
number and rate of the crude and standardized colorectal 
cancer mortality in the world in 2012 (Sorted by age-
standardized rate from the highest value to the lowest)
Standardized incidence rate and the HDI
It was observed a positive correlation of 0.712 
between the standardized incidence rate of colorectal 
cancer and the HDI (p≤0.001) (see Figure 4). Also it 
was seen a statistically significant correlation between 
human development index components with standardized 
rate. So that we had positive correlation of 0.513 
(p≤0.001) between the standardized incidence rate and 
life expectancy at birth, positive correlation of 0.641 
(p≤0.001) with average years of schooling and positive 
correlation of 0.514 (p≤0.001) with the level of income 
of the population per one person. 
Colorectal - Estimated mortality, all ages: both sexes Colorectal - Estimated mortality, all ages: male Colorectal - Estimated mortality, all ages: female
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Micronesia 40 7.3 8.3 South-Eastern Asia 24120 8.0 9.7 WHO Western Pacific 
region (WPRO)
99888 11.1 6.8
South-Eastern Asia 43234 7.1 7.9 South America 18347 9.3 9.4 South-Eastern Asia 19114 6.3 6.4
Latin America and 
Caribbean
48727 8.1 7.6 Caribbean 2238 10.7 9.1 Micronesia 16 5.9 6.4
Southern Africa 3264 5.6 7.4 Asia 185024 8.5 8.6 Asia 146591 7.1 6.0
Asia 331615 7.8 7.2 Latin America and 
Caribbean
23927 8.0 8.3 Middle-East and Northern 
Africa (MENA)
10776 4.9 5.8
Middle-East and North-
ern Africa (MENA)
23602 5.3 6.8 Micronesia/Polynesia 43 6.9 8.2 Southern Africa 1511 5.1 5.8
Medium Human Devel-
opment
245319 6.9 6.7 Medium Human 
Development
137997 7.6 8.0 Less developed regions 162526 5.7 5.6
Less developed regions 360768 6.2 6.6 Middle-East and 
Northern Africa 
(MENA)
12826 5.6 7.9 Medium Human Develop-
ment
107322 6.2 5.5
Micronesia/Polynesia 72 5.8 6.6 Less developed 
regions
198242 6.7 7.8 Micronesia/Polynesia 29 4.8 5.1
Melanesia 327 3.6 6.2 Melanesia 185 4.0 7.7 Melanesia 142 3.2 4.9
WHO South-East Asia 
region (SEARO)
84916 4.6 5.3 Polynesia 19 5.5 6.6 Eastern Africa 4629 2.6 4.6
Polynesia 32 4.7 5.3 WHO South-East Asia 
region (SEARO)
48093 5.1 6.3 Northern Africa 3909 3.8 4.5
Northern Africa 8296 4.0 5.0 Northern Africa 4387 4.2 5.6 WHO South-East Asia 
region (SEARO)
36823 4.1 4.4
Eastern Africa 9276 2.6 5.0 WHO East Mediter-
ranean region (EMRO)
11768 3.7 5.5 WHO East Mediterranean 
region (EMRO)
9523 3.1 4.3
WHO East 
Mediterranean region 
(EMRO)
21291 3.4 4.9 Eastern Africa 4647 2.7 5.5 Polynesia 13 3.9 4.2
Africa 29372 2.7 4.6 South-Central Asia 36992 4.0 5.1 WHO Africa region 
(AFRO)
11029 2.5 4.2
WHO Africa region 
(AFRO)
22344 2.5 4.6 Africa 15102 2.8 5.1 Africa 14270 2.7 4.2
Sub-Saharan Africa 21076 2.4 4.5 WHO Africa region 
(AFRO)
11315 2.6 5.0 Sub-Saharan Africa 10361 2.4 4.1
South-Central Asia 65359 3.6 4.4 Sub-Saharan Africa 10715 2.5 4.9 Middle Africa 1412 2.1 3.9
Central America 6460 4.0 4.3 Central America 3342 4.2 4.9 Central America 3118 3.8 3.8
Middle Africa 2624 2.0 3.9 Low Human Develop-
ment
16038 2.5 4.3 South-Central Asia 28367 3.2 3.8
Low Human 
Development
30149 2.3 3.9 Middle Africa 1212 1.8 3.8 Low Human Development 14111 2.2 3.5
Western Africa 5912 1.8 3.3 Western Africa 3103 1.9 3.5 Western Africa 2809 1.8 3.0
Table 2. (Continued) The Number and Rate of the Crude and Standardized Colorectal Cancer Mortality in the 
World in 2012 (Sorted by Age-Standardized Rate from the Highest Value to the Lowest)
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Colorectal Cancer Incidence and Mortality Correlations with the Human Development Index 
Figure 4. Correlation between HDI and Standardized 
Incidence Rate of Colorectal Cancer in the World in 
2012
	  
Figure 5. Correlation between HDI and Standardized 
Mortality Rate of Colorectal Cancer in the World in 
2012
	  
In males, a positive correlation of 0.688 between 
HDI and standardized incidence rate of colorectal cancer 
was statistically meaningful (p≤0.001). Also we had 
positive correlation between the components of HDI 
and standardized rate: 0.491 (p≤0.001) between the 
standardized incidence rate and life expectancy at birth, 
0.624 (p=0.047) with average years of schooling and 0.505 
(p≤0.001) with the level of income of the population per 
one person. 
In females, also a positive correlation of 0.725 between 
HDI and standardized incidence rate of colorectal cancer 
in women was statistically meaningful (p≤0.001). Also 
we had positive correlation between the components 
of HDI and standardized rate 0.528 (p≤0.001) for life 
expectancy at Birth, 0.644 (p=0.144) for average years 
of schooling and 0.512 (p≤0.001) for the level of income 
of the population per one person. 
Standardized mortality rate and the HDI
Also we had positive correlation of 0.628 between 
the standardized mortality rate of colorectal cancer and 
the HDI and it is statistically meaningful (p≤0.001) (see 
Figure 5). Also we had positive correlation between the 
components of HDI and standardized rate.  So that it can be 
seen positive correlation of 0.469 (p≤0.001) between the 
standardized mortality rate and life expectancy at Birth, 
positive correlation of 0.592 (p≤0.001) with average years 
of schooling and positive correlation of 0.378 (p≤0.001) 
with the level of income of the population per one person. 
It was seen a positive correlation of 0.599 between 
HDI and standardized mortality rate of colorectal cancer 
in men and it is statistically meaningful (p≤0.001). Also 
we had positive correlation between the components of 
HDI and standardized rate.  So that it can be seen positive 
correlation of 0.438 (p≤0.001) between the standardized 
mortality rate and life expectancy at Birth, positive 
correlation of 0.566 (p=0.047) with average years of 
schooling and positive correlation of 0.375 (p≤0.001) 
with the level of income of the population per one person.
It was seen a positive correlation of 0.621 between 
HDI and standardized mortality rate of colorectal cancer 
in women and it is statistically meaningful (p≤0.001). 
Also we had positive correlation between the components 
of HDI and standardized rate.  So that it can be seen 
positive correlation of 0.473 (p≤0.001) between the 
standardized mortality rate and life expectancy at Birth, 
positive correlation of 0.578 (p=0.047) with average years 
of schooling and positive correlation of 0.360 (p≤0.001) 
with the level of income of the population per one person.
Discussion
Colorectal cancer is the third most common cancer 
worldwide after lung and breast cancer (Jemal et al., 2011; 
Singh et al., 2014). Although the incidence and mortality 
of this cancer is decreasing in developed countries the 
incidence and mortality of this cancer has an increasing 
trend in developing countries (Jemal et al., 2011). 
The results of this study showed the highest standardized 
incidence rate for colorectal cancer in Korea, Republic of 
Slovakia and Hungary and of the six WHO regions, the 
most standardized incidence was for Europe. The previous 
global studies also showed the incidence of colorectal 
cancer higher for European countries (Jemal et al., 2011). 
Kamangar et al study showed the most standardized 
incidence rate for colorectal cancer for both sexes in 
Oceania, North America and Europe between 1993 and 
2001 respectively and standardized incidence rate for 
this cancer during the same period for more developed 
countries is shown too much higher than less developed 
countries (Kamangar et al., 2006). Also this study found 
the most standardized incidence based on HDI for Very 
High Human Development countries and the lowest one 
for low Human Development countries. The other global 
studies for other cancers such as lung, breast, prostate and 
stomach cancer showed the most cases for countries with 
very high Human Development Index and Medium Human 
Development Index (Bray et al., 2012). Various studies 
have shown relationship between the risk factors for 
types of cancers and other chronic diseases with HDI and 
development of countries. So one of the reasons for higher 
incidence rates of colorectal cancer in countries with high 
Human Development Index could be the common stage of 
risk factors in that countries (Corrao et al., 2000; Giebel 
Hosein Rafiemanesh et al
Asian Pacific Journal of Cancer Prevention, Vol 17, 20162472
et al., 2010; Bray et al., 2012; Ferrari and Reis, 2013; Liu 
et al., 2013). The etiology studies of Colorectal cancer 
diet (low fruit and vegeTable consumption, increased 
consumption of red meat) (Alikhani et al., 2009; Chan 
and Giovannucci, 2010; Alexander and Cushing, 2011; 
Aune et al., 2011; Key, 2011) and lifestyle (obesity, low 
physical activity, smoking) (Chan and Giovannucci, 2010; 
Donohoe et al., 2010). The global studies have shown a 
direct relationship between smoking capitation and the 
Human Development Index so that the highest capitation 
of cigarettes consumption was for countries with high 
Human Development Index (Corrao et al., 2000). Ferrari 
et al. (2013) study showed high Human Development 
Index in population is accompanied with increased obesity 
prevalence in men, increased alcohol, Cigarette, fruits and 
vegeTables capitation and increased red meat consumption 
and also with high HDI and high Stomach cancer incidence 
(Ferrari and Reis, 2013). 
The results of this study, showed the highest death rate 
of colorectal cancer for Hungary, Croatia and Slovakia 
respectively and also the lowest death for Mozambique, 
Zambia and Guinea. Based on the six WHO regions, the 
highest and lowest mortality was for Europe and Africa 
respectively. The standardized mortality rate based on 
Human Development Index showed a direct relationship 
and the most death was for countries with too high HDI 
rate. Also the studies all around the world showed the 
relationship between mortality from cancers (such as 
breast and bladder cancer) and the Human Development 
Index. Ghoncheh et al study that examines the association 
between incidence rate and standardized death of  Breast 
cancer and HDI, showed positive correlation (r-0.55) 
between Standardized Incidence rate (ASIR) and HDI 
and negative correlation (r=0.05) between standardized 
mortality from Breast cancer and HDI. Another study 
for bladder cancer showed positive correlation (r= 0.24 
(between standardized Incidence rate and HDI and weak 
positive correlation (r= 0.02) for standardized death rate 
(Pakzad et al., 2014; Ghoncheh et al., 2015b).  The same 
clear topic in these two studies is that the correlation 
between incidence rate and Human Development Index 
is much more stronger than the correlation between death 
and HDI. However, both studies were in Asian countries. 
This study that is in global level, showed strong correlation 
between both incidence rate with HDI (r= 0.71) and 
standardized death with HDI (r= 0.62). Anyway low 
mortality rate in countries with low Human Development 
Index can be due to the low incidence of colorectal cancer 
in these regions and also, lack of correct diagnosis and 
absence of registering and reporting this cancer as result 
(Coleman et al., 2008; Larsen et al., 2009; Coleman et al., 
2011; Jung et al., 2013; Mallin et al., 2013). Colorectal 
cancer mortality is associated with age and diagnosis, 
diagnosis stage, intervention type, location and race and 
these factors differ in countries with various levels of 
development (Torring et al., 2011; Aguero et al., 2012; 
Downing et al., 2013; Ahmadi et al., 2014; Perdue et al., 
2014).  Another reason for the difference in incidence and 
mortality of colorectal cancer with the development index 
of countries is the existence and usage of screening and 
diagnostic tests such as sigmoidoscopy and colonoscopy. 
Several studies have showed screening tests effective to 
reduce the incidence and specially mortality of colorectal 
cancer (Sunkara and Hebert, 2015; Zauber, 2015). 
Colorectal cancer is one of the world’s five leading cancer 
killer in both sexes (Ferlay et al., 2015) so it is clear that 
the countries that are on top of this cancer, also have a 
high mortality.
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